Johnson & Johnson has offered $9 billion to resolve talc lawsuits.

Image Source :- Google images

Johnson & Johnson has proposed to pay almost $9bn to resolve tens of thousands of lawsuits it faces in North America

Image Source :- Google images

that claim its baby powder and other talc-based products cause cancer.

Image Source :- Google images

Image Source :- Google images

The healthcare giant said it still believed the claims were "specious" 

Image Source :- Google images

but was hoping the new settlement offer would help conclude its legal battle.

Image Source :- Google images

The figure marks a big boost over the $2bn it had proposed previously.

Image Source :- Google images

The new offer has significant support from people tied to the case, it said.

Image Source :- Google images

The company is facing more than 40,000 lawsuits from former customers who say using its talc-based baby powder caused cancer, 

Image Source :- Google images

including some who allege the product contained cancer-causing asbestos.

Image Source :- Google images

It stopped US sales of its talc-based baby powder in 2020, citing "misinformation" that had sapped demand for the product,

Image Source :- Google images

applied to prevent nappy rash and for other cosmetic uses, including dry shampoo.

Image Source :- Google images

The company has been trying to resolve the lawsuits in bankruptcy court since 2021,

Image Source :- Google images

after creating a subsidiary responsible for the claims.

Image Source :- Google images

"The company continues to believe that these claims are specious and lack scientific merit," said Erik Haas,

Image Source :- Google images

worldwide vice president of litigation for Johnson & Johnson.

Image Source :- Google images

"Johnson & Johnson said it had won a majority of the talc lawsuits against it.

Image Source :- Google images

But it has been stuck with some significant losses,

Image Source :- Google images

including one decision in which 22 women were awarded a judgment of more than $2bn.